Brian Kilen (@briankilen)
Activity by Brian Kilen
Mayo Clinic hosting immersion program for innovative medical startups accelerating advances in patient care
ROCHESTER, Minn., — Mayo Clinic announced today a new collaboration with Techstars to offer the Techstars++ program. The Techstars++ program will bring together health care entrepreneurs and companies with Mayo Clinic to find innovative solutions to improve patient care at an accelerated pace. Mayo Clinic is the first to participate in this new program.
Techstars is a mentorship-driven accelerator program with a track record of helping to develop businesses, especially technology startups. The Techstars++ program offers companies from the Techstars portfolio of 500 alumni companies the opportunity to extend their Techstars experience by spending time on-site and engaging deeply with a corporation/organization - Mayo Clinic in this initial program. [...]
John Burnett Jr., M.D., a Mayo Clinic cardiologist, has been selected as a winner of GSK’s 2014 Discovery Fast Track Challenge, which is designed to accelerate the translation of academic research into novel therapies. Dr. Burnett will work with scientists in GSK’s Discovery Partnerships with Academia (DPAc) and the Molecular Discovery Research teams to test their hypotheses and screen targets against GSK’s compound collection.
Active compounds could then form the basis of full drug discovery programs that may ultimately lead to innovative medicines for anti-hypertensive agents.
Dr. Burnett submitted one of 14 winning proposals, chosen from 428 entries from 234 universities and academic institutes from across 26 countries. Research between Mayo Clinic and GSK will focus on treatments for resistant hypertension.
“We see this as a huge need, clinically, and we think our screen could lead to a breakthrough drug for the treatment of resistant hypertension, which is growing worldwide,” said Dr. Burnett. [...]
ROCHESTER, Minn. — Here are highlights from the November issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required. Include the following subscription information as your editorial policies permit: Visit http://www.healthletter.mayoclinic.com/ or call toll-free for subscription information, 1-800-333-9037, extension 9771. Full newsletter text: Mayo Clinic Health Letter November 2014 (for journalists only). Full special report text: Mayo Clinic Health Letter Special Report November 2014 (for journalists only).
New approaches for relief from irritable bowel syndrome
There are new approaches to manage the frustrating symptoms of irritable bowel syndrome (IBS), according to the November issue of Mayo Clinic Health Letter.
IBS is a common disorder of the large intestine (colon), characterized by abdominal pain that occurs before or along with diarrhea or constipation. Symptoms can vary widely. For many people, flares of diarrhea may last for a few days followed by periods of remission. Constipation may last for days or even months, along with intermittent diarrhea or normal bowel function. A small number of people with severe IBS have unbearable pain that is constant at times.
Multiple factors may contribute to the bowel dysfunction. The foundation of IBS therapy is developing lifestyle, exercise and diet changes that generally facilitate smooth bowel function. Treatment often includes working with a physician or other care provider to develop a plan for regular exercise and management of stress, anxiety and other psychological factors. [...]
ROCHESTER, Minn. ― Here are highlights from the October issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required. Include the following subscription information as your editorial policies permit: Visit http://healthletter.mayoclinic.com/ or call toll-free for subscription information, 1-800-333-9037, extension 9771. Full newsletter text: Mayo Clinic Health Letter October 2014 (for journalists only).
The new health phrase, “Sitting is the new smoking,” is not an exaggeration, according to the October issue of Mayo Clinic Health Letter. Most people don’t smoke, but everyone sits — and most sit too long each day. Many U.S. workers sit for 15 hours a day.
In the past 15 years, a wave of research has shed new light on sitting as a serious health risk, even in those of normal weight and who routinely exercise. Thirty-four chronic conditions and illnesses have been associated with excess sitting. One recent study compared adults who spent less than two hours a day watching television with those who spent more than four hours a day doing so. After adjusting for obesity, age and other risk factors, those with higher screen time had: [...]
ROCHESTER, Minn. ― Here are highlights from the September issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required. Include the following subscription information as your editorial policies permit: Visit http://www.HealthLetter.MayoClinic.com or call toll-free for subscription information, 1-800-333-9037, extension 9771. Full newsletter text: Mayo Clinic Health Letter September 2014 (for journalists only).
Adjusting from being a cancer patient to a cancer survivor isn't just about celebration and gratitude. The September issue of Mayo Clinic Health Letter covers why this transition isn’t always smooth or easy. In addition to dealing with fatigue or other side effects of surgery or treatment, patients may be surprised by feelings that can include fear and uncertainty, anxiety, sadness and irritability.
Mayo Clinic Center for Innovation Collaborates with Delos® to open first of its kind lab devoted to health and wellness in the built environment
ROCHESTER, Minn. — Delos®, the Pioneer of Wellness Real Estate™, and the Mayo Clinic Center for Innovation today announced their agreement to design, build and operate the newly formed WELL Living Lab — a multidisciplinary lab that will be uniquely focused on the interaction between health, wellness and the built environment. Set to debut in April 2015 adjacent to Mayo Clinic’s Rochester campus in downtown Rochester, the WELL Living Lab will be the first lab exclusively committed to research, development and testing of both new and existing innovations designed to improve the health and well-being of individuals as they live and work within built environments.
An open-innovation ecosystem for healthy living, the WELL Living Lab will simulate realistic living and working environments, including homes, offices, schools, communities and hotels in order to test, monitor and identify the efficacy of wellness-based interventions. The lab will incorporate state-of-the-art technology and unique design elements that will create a dynamic, versatile and highly adaptable environment, allowing for a wide range of simulated real-world conditions. Delos® and Mayo Clinic Center for Innovation will co-govern the lab, which will be staffed by Mayo Clinic personnel, along with members of the Delos® team.
ROCHESTER, Minn. –– The American Legion presented Donald Jenkins, M.D., a Mayo Clinic trauma surgeon and retired Air Force colonel, with its highest award, the Distinguished Service Medal, for his achievements in trauma and critical medical care for military personnel injured in Iraq and Afghanistan.
The American Legion, chartered by Congress in 1919, focuses on serving veterans, current service members and communities. Since 1921, the American Legion Distinguished Service Medal has been presented to individuals who have demonstrated outstanding service to the nation and have made great contributions to veterans.
Among Dr. Jenkins significant contributions to medical care for service members is his instrumental role in founding the military’s first trauma system, the Joint Theater Trauma System. The goal of the system is to provide the optimal chance for survival and maximal potential for functional recovery among injured military personnel. A trauma system organizes and coordinates efforts to deliver a full range of trauma care for a population. [...]
Stool-based DNA (sDNA) screening test for colorectal cancer to be available by prescription to patients
News Conference Advisory: An audio news conference was held this morning with representatives from Exact Sciences Corp. and Mayo Clinic.
MADISON, Wis., and ROCHESTER, Minn., — Exact Sciences Corp. (NASDAQ: EXAS) today announced that Mayo Clinic will be the first health system to offer Cologuard®, the first and only Food and Drug Administration (FDA) approved, noninvasive stool DNA screening test for colorectal cancer. Cologuard will be available to patients through their primary care physicians at Mayo Clinic.
Available by prescription only, Cologuard offers people 50 years and older who are at average risk for colorectal cancer an easy to use screening test which they can do in the privacy of their own home. It is the first noninvasive screening test for colorectal cancer that analyzes both stool-based DNA and blood biomarkers to detect cancer and precancer. The Cologuard technology platform was co-developed by Exact Sciences Corp. and Mayo Clinic as part of a broad, exclusive collaboration.
“Cologuard represents a significant advancement in identifying colorectal cancer at its most treatable stage. We believe offering this new tool will promote patient and community public health and may move more patients to get screened earlier—a critical step in beating this prevalent and preventable cancer,” says Vijay Shah, M.D., chair of Mayo Clinic gastroenterology and hepatology.
Journalists: Video is available in the downloads.